Researchers at University of Tsukuba have discovered that an immunosuppressive drug affects microglia, the resident immune ...
A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response ...
Study suggests that persistently activated ATF6α is a tumor driver, a potential stratification marker for immunotherapy response, and a therapeutic target for HCC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results